Boston Scientific Corp's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Selling-General-and-Administrative" stands at 7.16 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the highest value at least since 12/31/2012, the period currently displayed.
Boston Scientific Corp's second quarter result of 1.80 Billion USD for the item "Selling General and Administrative" represents an increase of 1.24 percent compared to it's first quarter result.
Also, Boston Scientific Corp's second quarter result of 1.80 Billion USD for the item "Selling General and Administrative" represents an increase of 5.07 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Boston Scientific Corp's second quarter result of 7.16 Billion USD for the item "Selling General and Administrative" represents an increase of 1.23 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.36 percent compared to the value the year prior.
The 1 year change in percent is 10.36.
The 3 year change in percent is 303.78.
The 5 year change in percent is 72.71.
The 10 year change in percent is 138.39.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Abbott Laboratories - Selling General and Administrative | 217,696,616,448.00 |
![]() | Intuitive Surgical Inc - Selling General and Administrative | 206,245,888,000.00 |
![]() | EssilorLuxottica S. A. - Selling General and Administrative | 172,241,486,586.05 |
![]() | Danaher Corporation - Selling General and Administrative | 162,006,663,168.00 |
![]() | Stryker Corporation - Selling General and Administrative | 139,209,850,880.00 |